Skip to content

The effectiveness and safety of Chinese medicine in the treatment of novel coronavirus pneumonia: A Real World Study

The effectiveness and safety of Chinese medicine in the treatment of novel coronavirus pneumonia: A Real World Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061441
Enrollment
Unknown
Registered
2022-06-25
Start date
2022-03-14
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

asymptomatic infection group:Qingfeipaidu Granules
mild infection group:Qingfeipaidu Granules

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 84 Years

Inclusion criteria

Inclusion criteria: 1. Mild infection (mild clinical symptoms, no signs of pneumonia on imaging) and asymptomatic infection (positive etiological test of COVID-19 but no related clinical manifestations); 2. Capable of independent behavior; 3. No serious concomitant diseases, such as acute myocardial infarction, acute cerebral hemorrhage, malignant arrhythmia, acute heart failure and renal failure, etc.; 4. Urine pregnancy test was negative; 5. At rest, blood oxygen saturation (SPO2) >= 93%, respiratory rate =1d.

Exclusion criteria

Exclusion criteria: 1. Lactating patients; 2. Patients whose hospitalization information is not available; 3. Patients with previous allergy to traditional Chinese medicine recorded in their allergy history; 4. Liver and kidney insufficiency; 5. At rest, it refers to blood oxygen saturation (SPO2) = 30 times/min.

Design outcomes

Primary

MeasureTime frame
Nucleic acid conversion rate;Clinical progression rate;

Secondary

MeasureTime frame
The time of nucleic acid test turnaround;

Countries

China

Contacts

Public ContactJia Xinhua

Shandong University of Traditional Chinese Medicine

jiaxinhua_jn@163.com+86 18660103522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026